Accelerating global access

Our company is collaborating with a range of partners to enable access for patients around the world

September 8, 2022

Share this article


hands with a globe illustration

At the outset of our research efforts for COVID-19, our company made clear its commitment to make any vaccine or medicine we develop for this pandemic broadly accessible.

Here’s how we have been working to fulfill that commitment:

Access to our antiviral infographic

Download the infographic